Purple Biotech Ltd
PPBT
$3.95
$0.102.55%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -7.24M | -11.66M | |
| Total Depreciation and Amortization | -- | -- | 186.00K | 194.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | -2.98M | -3.60M | |
| Change in Net Operating Assets | -- | -- | -4.33M | -2.27M | |
| Cash from Operations | -- | -- | -14.37M | -17.34M | |
| Capital Expenditure | -- | -- | -- | 0.00 | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | 0.00 | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -- | 509.00K | 545.00K | |
| Cash from Investing | -- | -- | 509.00K | 545.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -183.00K | -177.00K | |
| Issuance of Common Stock | -- | -- | 7.84M | 3.47M | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -880.00K | 3.78M | |
| Cash from Financing | -- | -- | 6.77M | 7.08M | |
| Foreign Exchange rate Adjustments | -- | -- | -4.00K | 43.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | -7.09M | -9.67M | |